N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143012 |
| CAS No | NA |
| Mol.F. | C14H11N5O3S |
| Mol.Wt. | 329.33g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143013 |
| CAS No | NA |
| Mol.F. | C16H13F3N4O3S |
| Mol.Wt. | 398.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143014 |
| CAS No | NA |
| Mol.F. | C16H13F3N4O5S |
| Mol.Wt. | 430.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143015 |
| CAS No | 58858-73-4 |
| Mol.F. | C6H6ClN3O |
| Mol.Wt. | 171.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143016 |
| CAS No | NA |
| Mol.F. | C7H16N2O3 |
| Mol.Wt. | 176.22 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143017 |
| CAS No | NA |
| Mol.F. | C21H22N2O4 |
| Mol.Wt. | 366.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143018 |
| CAS No | NA |
| Mol.F. | C17H18ClN3O |
| Mol.Wt. | 315.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143019 |
| CAS No | NA |
| Mol.F. | C10H11CIN2O2 |
| Mol.Wt. | 226.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143020 |
| CAS No | 2659259-66-0 |
| Mol.F. | C7H12N2O2 |
| Mol.Wt. | 156.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143021 |
| CAS No | NA |
| Mol.F. | C10H12N2O2 |
| Mol.Wt. | 192.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143022 |
| CAS No | NA |
| Mol.F. | C14H21N3O2 |
| Mol.Wt. | 263.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143023 |
| CAS No | NA |
| Mol.F. | C14H21N3O2 |
| Mol.Wt. | 263.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143024 |
| CAS No | NA |
| Mol.F. | C13H19N3O2 |
| Mol.Wt. | 249.31g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143025 |
| CAS No | NA |
| Mol.F. | C14H17N3O2 |
| Mol.Wt. | 259.31g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143026 |
| CAS No | NA |
| Mol.F. | C14H21N3O3 |
| Mol.Wt. | 279.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143027 |
| CAS No | NA |
| Mol.F. | C14H22N3O6S |
| Mol.Wt. | 360.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |